Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
Currency:  $
Discounted Reports
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare

Global Endometriosis Market 2012-2016

Enquire | Email | Print

Published Date: Jun, 2013
Format: PDF
No of Pages: 49
Select pricing :
Change Currency: EURO | $ USD | GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

TechNavio's analysts forecast the Global Endometriosis market to grow at a CAGR of 5.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased number of incidence rates of endometriosis. The market has also been witnessing an increased number of awareness programs. However, poor safety and efficacy of existing drugs could pose a challenge to the growth of this market.

The Global Endometriosis Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Endometriosis market in the Americas, EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space include AbbVie Inc., AstraZeneca Plc., Bayer Inc., and Pfizer Inc.

The other vendors mentioned in the report are AEterna Zentaris Inc., KV Pharmaceuticals Company, Neurocrine Biosciences Inc., and Repros Therapeutics Inc.

Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
4.1. Market Research Process
4.2. Research Design
4.3. Research Methodology
5. Scope of the Report
5.1. Market Overview
5.2. Product Offerings
5.3. Product Profiles
6. Market Landscape
6.1. Global Endometriosis Market 2012-2016
6.1.1. Market Size and Forecast
7. Five Force Analysis
8. Geographical Segmentation
9. Rate of Incidence and Prevalence
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1. AbbVie Inc.
17.1.1. Business Overview
17.1.2. Key Information
17.1.3. SWOT Analysis
17.2. Pfizer Inc.
17.2.1. Business Overview
17.2.2. Key Information
17.2.3. SWOT Analysis
17.3. AstraZeneca PLC.
17.3.1. Business Overview
17.3.2. Key Information
17.3.3. SWOT Analysis
17.4. Bayer Inc.
17.4.1. Business Overview
17.4.2. Key Information
17.4.3. SWOT Analysis
18. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Endometriosis Market 2012-2016 (US$ billion)
Exhibit 3: Therapies Used in the Treatment of Endometriosis
Exhibit 4: Therapies Used in the Treatment of Endometriosis (in percentage)
Exhibit 5: Global Endometriosis Market by Geographical Segmentation 2012

Related Reports:  


Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.


Top Go to top of the page

product id: 403442, price: INR 120808, Technavio

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
About Trust Online